Latest Blogs

Guest Commentary
Mar 21, 2023
My Journey Through the Hematology / Oncology Fellowship Match
Dr. Michael LaPelusa shares his recent start-to-finish experience going through the Fellowship Match, with tips for preparing your application, interviewing, and telling your unique professional story.
Guest Commentary
Mar 16, 2023
Set Up Your Collaborative Team for Success: A Guideline for Advanced Practice Provider/Physician Team-Based Care in Oncology
Clear expectations are key for effective teamwork. Tammy Triglianos, Dr. Ethan Basch, and Dr. Matthew Milowsky share a guidance document to facilitate excellent collaboration in advanced practice provider/physician teams.
Guest Commentary
Mar 14, 2023
Geriatric Oncology: A Training Opportunity That Has Come of Age
Four geriatric oncology experts answer five questions about the field, including what oncology trainees need to know, how to pursue consolidated training, and why geriatric oncology is a meaningful and rewarding career.
International Perspectives
Mar 14, 2023
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
Dr. Khalid El Bairi was invited to participate in the International Summit of Health Professionals in Pakistan, a country he only knew from the news and nature documentaries. The visit challenged his perceptions and allowed him to make valuable connections.
Subscribe to this column

Peter Paul Yu, MD, FASCO, FACP

Peter Paul Yu, MD, FACP, FASCO, is the physician-in-chief at Hartford HealthCare Cancer Institute. He is a past president of ASCO, past chair of the Breakthrough Co-Host Committee, and currently serves on the CancerLinQ Board of Governors, as an associate editor of JCO Clinical Cancer Informatics, and on the JCO Oncology Practice editorial board. Follow Dr. Yu on Twitter @YupOnc.

Disclosure.

Jun 02, 2014
Illumination and Innovation: Transforming Data into Learning
“Illumination” is a provocative word, evoking as it does the banishment of the darkness of ignorance by the light of new knowledge. Today, we are benefiting from a steady stream of new knowledge about the molecular basis of cancer and the interaction between host and tumor immunology. The concept...
Feb 15, 2014
Saluting Our Members
During the last few months, I have been visiting with as many of the 21 ASCO committees as I can in order to understand the issues that they have identified as most critical for cancer education, research, and patient well being. I have been impressed by the richness of vision and dedication that...
Nov 23, 2013
The Prepared Mind
By chance this week, I experienced a juxtaposition of polar opposites that gave pause for reflection on where we are heading with research that informs advancement in cancer care. For the first two days, I attended the Patient-Centered Outcomes Research Institute  (PCORI) Workshop Integrating PROS...
Oct 21, 2013
Pathways: How Do We Know They Got It Right?
By my watch, I am somewhere over Lincoln, Nebraska, flying back from the ASCO Provider-Payer Initiative (PPI) Meeting. It’s the third annual PPI meeting and the fact that it exists is significant evidence of ASCO's ability to adapt in response to circumstances and of the increasing resources that...
4 Comments
Oct 14, 2013
The Way We Were: Facing the Changing Needs of Community Practices
There are over 33,000 ASCO members now, and the size and diversity of our membership increases the challenge of keeping the Society in touch with the concerns and opinions that matter the most to our members, the concerns that wake us up in the middle of the night or occupy a good part of our...
Oct 07, 2013
The Way Forward: Realizing the Promise of Precision Medicine and Big Data
The Atlantic Magazine, together with the University of California San Diego, sponsored a two-day symposium on cancer, highlighting the impact of new technology and drawing upon speakers across the spectrum of the oncology community:...

Pages